Belastungsinduzierte Veränderungen von Thrombozyten ...

Literaturliste
51. Cox D. 1998. Methods for monitoring platelet function. Am Heart J;135(5 Pt 2 Su):S160-
9.
52. Dale G. L., Friese P., Hynes L. A., Burstein S. A. 1995. Demonstration that Thiazole
Orange-positive platelets in the dog are less than 24 hours old. Blood;85:1822-1825.
53. Dale G. L. 1997. Platelet kinetics. Curr Opin Hematol;4(5):330-4.
54. Davies M. J., Thomas A. C., Knapman P. A., Hangartner J. R. 1986. Intramyocardial
platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death.
Circulation;73(3):418-27.
55. Dawes J., Smith R. C., Pepper D. S. 1978. The release, distribution, and clearance of
human beta-thromboglobulin and platelet factor 4. Thromb Res;12(5):851-61.
56. Dawson A. A., Ogston D. 1969. Exercise-induced thrombocytosis. Acta
Haematol;42(4):241-6.
57. de Bruijne-Admiraal L. G., Modderman P. W., von dem Borne A. E. G., Sonnenberg A.
1992. P-Selectin Mediates Ca2+-dependent Adhesion of Activated Platelets to Many
Different Types of Leukocytes: Detection by Flow Cytometry. Blood;80:134-142.
58. de Groot P. G., Sixma J. J. 1999. Glykoproteinrezeptoren der Thrombozytenmembran:
Biochemie, Molekularbiologie und Physiologie. In: Müller-Berghaus G, Pötzsch B, editors.
Hämostaseologie. Berlin Heidelberg New York: Springer Verlag. p. 15-26.
59. de Man F. H., Nieuwland R., van der Laarse A., Romijn F., Smelt A. H., Gevers Leuven J.
A., Sturk A. 2000. Activated platelets in patients with severe hypertriglyceridemia: effects of
triglyceride-lowering therapy. Atherosclerosis;152(2):407-14.
60. de Meirelles L. R., Mendes-Ribeiro A. C., Mendes M. A., da Silva M. N., Ellory J. C.,
Mann G. E., Brunini T. M. 2008. Chronic exercise reduces platelet activation in hypertension:
upregulation of the l-arginine-nitric oxide pathway. Scand J Med Sci Sports;2008 Feb. 1 Epup
ahead of print.
61. DeCaterina M., Grimaldi E., Ungaro B., Fratellanza G., Varriale V., Ciarnelli M.,
Scopacasa f. 2002. Effects of paraformaldehyde on platelet size and on measurement of
surface IgG. Platelets;13:207-212.
62. Di Massimo C., Scarpelli P., Penco M., Tozzi-Ciancarelli M. G. 2004. Possible involment
of plasma antioxidant defences in training-associated decrease of platelet responsivness in
humans. Eur J Appl Physiol;91:406-412.
63. Dickhuth H. H., Röcker K., Mayer F., Nieß A., Horstmann T., Heitkamp H. C., Dolezel P.
1996. Bedeutung der Leistungsdiagnostik und Trainingssteuerung bei Ausdauer- und
Spielsportarten. Dtsch Z Sportmed;47:183-189.
64. Dill D. B., Costill D. L. 1974. Calculation of percentage changes in volumes of blood,
plasma, and red cells in dehydration. J Appl Physiol;37(2):247-8.
65. Dimitriadou C., Dessypris A., Louizou C., Mandalaki T. 1977. Marathon run II: Effects
on platelet aggregation. Thromb Haemost;37(3):451-5.
66. Dimitriu-Bona A., Burmester G. R., Waters S. J., Winchester R. J. 1983. Human
mononuclear phagocyte differentiation antigens. I. Patterns of antigenic xpression on the
surface of human monocytes and macrophages defined by monoclonal antibodies. J
Immunol;130:145 ff.
67. Dore M. 1998. Platelet-leukocyte interactions. Am Heart J;135(5 Pt 2 Su):S146-51.
116